Aprea Therapeutics, Inc. (APRE): Depreciation & Amortization
$21.7K
Year ended 2025-12-31
$22.0K
Trailing 12 months to 2026-06-30
+70.2%
3-year compound annual growth
-5.5%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $21.7K | -2.7% | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | $22.3K | +216.5% | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | $7.1K | +60.2% | 2025-03-25, From 2023-01-01 |
| 2022-12-31 | $4.4K | -65.7% | 2024-03-26, From 2022-01-01 |
| 2021-12-31 | $12.8K | -55.5% | 2024-03-26, From 2021-01-01 |
| 2020-12-31 | $28.8K | +159.2% | 2023-03-30, From 2020-01-01 |
| 2019-12-31 | $11.1K | +33.8% | 2022-03-15, From 2019-01-01 |
| 2018-12-31 | $8.3K | +4.8% | 2021-03-16, From 2018-01-01 |
| 2017-12-31 | $7.9K | n/a | 2020-03-27, From 2017-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Aprea Therapeutics, Inc. (APRE) | 2025-12-31 | $21.7K | -2.7% |
| Cellectar Biosciences, Inc. (CLRB) | 2025-12-31 | $213.6K | -26.8% |
| Lipocine Inc. (LPCN) | 2025-12-31 | $60.8K | +47.9% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $1.15M | +2.3% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $146.0K | -16.1% |
| Exicure, Inc. (XCUR) | 2025-12-31 | $242.0K | +764.3% |
| CytoDyn Inc. (CYDY) | 2026-05-31 | $17.0K | -5.6% |
| Allarity Therapeutics, Inc. (ALLR) | 2024-12-31 | $9.0K | -75.7% |
| Lite Strategy, Inc. (LITS) | 2025-06-30 | $368.0K | -3.9% |
Compare APRE, CLRB, LPCN, IBO side by side · Screen every company in Pharmaceutical Preparations ↗